Astellas Pharma Inc 2012 SR
The report highlights Astellas Pharma's environmental performance for fiscal 2011, focusing on global warming prevention, resource recycling, and biodiversity. The company achieved significant reductions in greenhouse gas emissions and water consumption, partly due to operational changes and impacts from the Great East Japan Earthquake. Key initiatives included converting to alternative fuels like LNG, installing wind turbines and biomass boilers, and maintaining zero waste emissions in Japan. Astellas also introduced a biodiversity index to quantify its impact and progress toward 2020 targets.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2012
Type: SR
Pages: 28
Astellas Pharma Inc
The report highlights Astellas Pharma's environmental performance for fiscal 2011, focusing on global warming prevention, resource recycling, and biodiversity. The company achieved significant reductions in greenhouse gas emissions and water consumption, partly due to operational changes and impacts from the Great East Japan Earthquake. Key initiatives included converting to alternative fuels like LNG, installing wind turbines and biomass boilers, and maintaining zero waste emissions in Japan. Astellas also introduced a biodiversity index to quantify its impact and progress toward 2020 targets.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2012
Reporting Period
Jan 1, 2011 - Mar 31, 2012
Fiscal Year
2011
Published
Jun 1, 2012
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste